TD Asset Management Inc. boosted its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 1.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 630,360 shares of the medical research company’s stock after buying an additional 8,612 shares during the period. TD Asset Management Inc.’s holdings in Agilent Technologies were worth $37,387,000 at the end of the most recent reporting period.
A number of other large investors have also recently modified their holdings of A. Cribstone Capital Management LLC increased its stake in shares of Agilent Technologies by 2.3% in the first quarter. Cribstone Capital Management LLC now owns 2,359 shares of the medical research company’s stock valued at $125,000 after buying an additional 54 shares during the last quarter. Trust Co. of Vermont increased its stake in shares of Agilent Technologies by 8.1% in the first quarter. Trust Co. of Vermont now owns 2,743 shares of the medical research company’s stock valued at $145,000 after buying an additional 205 shares during the last quarter. CENTRAL TRUST Co boosted its position in Agilent Technologies by 15.3% in the first quarter. CENTRAL TRUST Co now owns 2,994 shares of the medical research company’s stock valued at $158,000 after buying an additional 398 shares during the period. Genovese Burford & Brothers Wealth & Retirement Plan Management LLC boosted its position in Agilent Technologies by 17.2% in the second quarter. Genovese Burford & Brothers Wealth & Retirement Plan Management LLC now owns 3,319 shares of the medical research company’s stock valued at $196,000 after buying an additional 486 shares during the period. Finally, ELM Advisors LLC bought a new position in Agilent Technologies during the second quarter valued at $202,000.
Agilent Technologies, Inc. (NYSE:A) opened at 59.68 on Thursday. The company’s 50-day moving average is $60.17 and its 200 day moving average is $55.58. Agilent Technologies, Inc. has a one year low of $42.92 and a one year high of $61.84. The firm has a market cap of $19.18 billion, a PE ratio of 33.55 and a beta of 1.30.
Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Monday, May 22nd. The medical research company reported $0.58 EPS for the quarter, beating the Zacks’ consensus estimate of $0.48 by $0.10. The business had revenue of $1.10 billion during the quarter, compared to analyst estimates of $1.05 billion. Agilent Technologies had a net margin of 13.41% and a return on equity of 16.49%. Agilent Technologies’s quarterly revenue was up 8.1% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.44 EPS. Equities analysts anticipate that Agilent Technologies, Inc. will post $2.23 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which was paid on Wednesday, July 26th. Shareholders of record on Monday, July 3rd were paid a dividend of $0.132 per share. The ex-dividend date was Thursday, June 29th. This represents a $0.53 dividend on an annualized basis and a yield of 0.88%. Agilent Technologies’s dividend payout ratio (DPR) is presently 29.78%.
WARNING: This piece was posted by Ticker Report and is the property of of Ticker Report. If you are viewing this piece on another site, it was copied illegally and republished in violation of U.S. & international copyright law. The correct version of this piece can be viewed at https://www.tickerreport.com/banking-finance/2798031/agilent-technologies-inc-nysea-position-increased-by-td-asset-management-inc.html.
Several research analysts have recently weighed in on the stock. Wells Fargo & Company upgraded shares of Agilent Technologies from a “market perform” rating to an “outperform” rating and upped their price target for the company from $42.92 to $60.73 in a report on Wednesday, July 12th. BidaskClub upgraded shares of Agilent Technologies from a “buy” rating to a “strong-buy” rating in a report on Tuesday, July 11th. Jefferies Group LLC reiterated a “buy” rating and issued a $66.00 price target on shares of Agilent Technologies in a report on Wednesday. Robert W. Baird upped their price target on shares of Agilent Technologies from $57.00 to $62.00 and gave the company an “outperform” rating in a report on Wednesday, May 24th. Finally, Morgan Stanley reiterated an “overweight” rating on shares of Agilent Technologies in a report on Monday, July 10th. Two analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $60.12.
In other Agilent Technologies news, CFO Didier Hirsch sold 5,710 shares of the business’s stock in a transaction on Thursday, June 1st. The shares were sold at an average price of $60.60, for a total transaction of $346,026.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Patrick Kaltenbach sold 5,000 shares of the business’s stock in a transaction on Thursday, July 13th. The shares were sold at an average price of $61.26, for a total transaction of $306,300.00. Following the sale, the insider now owns 45,138 shares of the company’s stock, valued at approximately $2,765,153.88. The disclosure for this sale can be found here. Insiders have sold a total of 112,608 shares of company stock valued at $6,737,509 in the last 90 days.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A).
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.